MIA PaCa-2
MIA PaCa-2 is a human
cell line used extensively in pancreatic cancer research and therapy development.[1]
In 1977,[2] MIA PaCa-2 cells were derived from the carcinoma of a 65-year-old male.[citation needed]
The cells exhibit
CD56.[1] The cells have a round, epithelial morphology, and are adherent in cell culture
.
MIA PaCa-2 has served for decades as a model of pancreatic cancer, and studies of MIA PaCa-2 physiology have helped clarify the mechanisms of
lysates targeting IgG production,[3] and augmented drug-delivery methods relying on quantum dots.[4]
See also
References
- ^ PMID 26884312.
- PMID 15590.
- ISBN 9781681080239.
- ISBN 9783319113555.